Is lack of peripheral tolerance induction a cause for diabetes in the non-obese diabetic mouse?

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 5, 2000, Pages 405-416

  Lund, Torben ^a   Strid, Jessica ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antigen presenting cells; Non obese diabetic mouse; Peripheral tolerance

Indexed keywords

ANIMAL; DENDRITIC CELL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONOBESE DIABETIC MOUSE; REVIEW;

ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICE; MICE, INBRED NOD; SELF TOLERANCE;

EID: 0041402729     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. BANCHEREAU J. and STEINMAN R. M. (1998): Dendritic cells and the control of immunity. Nature, 392, 245-252.
2. BENHAMOU P. Y., MULLEN Y., CLARE-SALZLER M., SANGKHARAT A., BENHAMOU C., SHEVLIN L. and GO V. L. (1995): Essential fatty acid deficiency prevents autoimmune diabetes in nonobese diabetic mice through a positive impact on antigen-presenting cells and Th2 lymphocytes. Pancreas, 11, 26-37.
3. g7 molecules from nonobese diabetic mice are poor peptide binders. J. Immunol., 156, 450-458.
4. CLARE-SALZLER M. J., BROOKS J., CHAI A., VANHERLE K. and ANDERSON C. (1992): Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest., 90, 741-748.
5. COLEMAN D. L., KUZAVA J. E. and LEITER E. H. (1990): Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes, 39, 432-436.
6. DELEMARRE F. G., SIMONS P. J., DE HEER H. J. and DREXHAGE H. A. (1999): Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: consequences for the in vitro expansion of regulator and effector T cells. J. Immunol., 162, 1795-1801.
7. DE LUCA D., BLUESTONE J. A., SHULTZ L. D., SHARROW S. O. and TATSUMI Y. (1995): Programmed differentiation of murine thymocytes during fetal thymus organ culture. J. Immunol. Methods, 178, 13-29.
8. DELVES P. J. (1998): The role of glycosylation in autoimmune disease. Autoimmunity, 27, 239-253.
9. FEARON D. T. and LOCKSLEY R. M. (1996): The instructive role of innate immunity in the acquired immune response. Science, 272, 50-54.
10. GALLUCCI S., LOLKEMA M. and MATZINGER P. (1999): Natural adjuvants: endogenous activators of dendritic cells. Nat. Med., 5, 1249-1255.
11. GAZDA L. S., CHARLTON B. and LAFFERTY K. J. (1997): Diabetes results from a late change in the autoimmune response of NOD mice. J. Autoimmun., 10, 261-270.
12. HATTORI M., YAMATO E., ITOH N., SENPUKU H., FUJISAWA T., YOSHINO M., FUKUDA M., MATSUMOTO E., TOYONAGA T., NAKAGAWA I., PETRUZZELLI M., MCMURRAY A., WEINER H., SAGAI T., MORIWAKI K., SHIROISHI T., MARON R. and LUND T. (1999): Cutting edge: Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. J. Immunol., 163, 1721-1724.
13. HUTCHINGS P., ROSEN H., O'REILLY L., SIMPSON E., GORDON S. and COOKE A. (1990): Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature, 348, 639-642.
14. IKEGAMI H., MAKINO S., YAMATO E., KAWAGUCHI Y., UEDA H., SAKAMOTO T., TAKEKAWA K. and OGIHARA T. (1995): Identification of a new susceptibility locus for insulin-dependent diabetes-mellitus by ancestral haplotype congenic mappingI. J. Clin. Invest., 96, 1936-1942.
15. JACOB C. O., AISO S., MICHIE S. A., MCDEVITT H. O. and ACHA O. H. (1990): Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA, 87, 968-972.
16. JACOB C. O., LEE S. K. and STRASSMAN G. (1996): Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J. Immunol., 156, 3043-3050.
17. JANSEN A., HOMODELARCHE F., HOOIJKAAS H., LEENEN P. J., DARDENNE M. and DREXHAGE H. A. (1994): Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes, 43, 667-675.
18. g7 -dependent reaction. Proc. Natl. Acad. Sci. USA, 95, 1721-1724.
19. KAPSENBERG M. L., HILKENS C. M., WIERENGA E. A. and KALINSKI P. (1999): The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin. Exp. Allergy, 29 (suppl. 2), 33-36.
20. KATZ J. D., WANG B., HASKINS K., BENOIST C. and MATHIS D. (1993): Following a diabetogenic T cell from genesis through pathogenesis. Cell, 74, 1089-1100.
21. KROEMER G., HIRSCH F., GONZALEZ-GARCIA A. and MARTINEZ C. (1996): Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity, 24, 25-33.
22. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med., 186, 2057-2062.
23. + T cells. J. Exp. Med., 186, 239-245.
24. LANGMUIR P. B., BRIDGETT M. M., BOTHWELL A. L. M. and CRISPE I. N. (1993): Bone-marrow abnormalities in the nonobese diabetic mouse. Int. Immunol., 5, 169-177.
25. LUND T., O'REILLY L., HUTCHJNGS P., KANAGAWA O., SIMPSON E., GRAVELY R., CHANDLER P., DYSON J., PICARD J. K., EDWARDS A., KIOUSSIS D. and COOKE A. (1990): Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature, 345, 727-729,
26. LUND T., SHAIKH S., KENDALL E., CAMPBELL R. D., HATTORI M., MAKINO S. and COOKE A. (1993): RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains. Diabetologia, 36, 727-733.
27. MAKINO S., KUNIMOTO K., MURAOKA Y., MIZUSHIMA Y., KATAGIRI K. and TOCHINO Y. (1980): Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu, 29, 1-13.
28. MARASKOVSKY E., BRASEL K., TEEPE M., ROUX E. R., LYMAN S. D., SHORTMAN K. and MCKENNA H. J. (1996): Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med., 184, 1953-1962.
29. MEDZHITOV R. and JANEWAY C. A. JR. (1997): Innate immunity: the virtues of a nonclonal system of recognition. Cell, 91, 295-298.
30. MEDZHITOV R. and JANEWAY C. A. JR. (1997): Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol., 9, 4-9.
31. MIYAZAKI T., MATSUDA Y., TOYONAGA T., MAYAZAKI J., YAZAKI Y. and YAMAMURA K. (1992): Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class-I Ld molecules. Proc. Natl. Acad. Sci. USA, 89, 9519-9523.
32. MONDINO A., KHORUTS A. and JENKINS M. K. (1996): The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA, 93, 2245-2252.
33. NISHIMOTO H., KIKUTANI H., YAMAMURA K. and KISHIMOTO T. (1987): Prevention of autoimmune insulitis by expresion of I-E molecules in NOD mice. Nature, 328, 432-434.
34. OHASHI P. S., OEHEN S., BUERKI K., PIRCHER H., OHASHI C. T., ODERMATT B., MALISSEN B., ZINKERNAGEL R. M. and HENGARTNER H. (1991): Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell, 65, 305-317
35. OLDSTONE M. B., NERENBERG M., SOUTHERN P., PRICE J. and LEWICKI H. (1991): Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell, 65, 319-331.
36. PIERRE P., TURLEY S. J., GATTI E., HULL M., MELTZER J., MIRZA A., INABÁ K., STEINMAN R. M. and MELLMAN I. (1997): Developmental regulation of MHC class II transport in mouse dendritic cells. Nature, 388, 787-792.
37. PONTESILLI O., CAROTENUTO P., GAZDA L. S., PRATT P. F. and PROWSE S. J. (1987): Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol., 70, 84-93.
38. PULENDRAN B., LINGAPPA J., KENNEDY M. K., SMITH J., TEEPE M., RUDENSKY A., MALISZEWSKI C. R. and MARASKOVSKY E. (1997): Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol., 159, 2222-2231.
39. PULENDRAN B., SMITH J. L., CASPARY G., BRASEL K., PETTIT D., MARASKOVSKY E. and MALISZEWSKI C. R. (1999): Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA, 96, 1036-1041.
40. PULENDRAN B., SMITH J. L., JENKINS M., SCHOENBORN M., MARASKOVSKY E. and MALISZEWSKI C. R. (1998): Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J. Exp. Med., 188, 2075-2085.
41. g7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes-mellitus. J. Immunol., 154, 5567-5575.
42. RABINOVITCH A. (1994): Immunoregulatory and cytokine imbalances in the pathogensis of IDDM. Diabetes, 43, 613-621.
43. RADEMACHER T. W., WILLIAMS P. and DWEK R. A. (1994): Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA, 91, 6123-6127.
44. RAPOPORT M. J., JARAMILLO A., ZIPRIS D., LAZARUS A. H., SERREZE D. V., LEITER E. H., CYOPICK P., DANSKA J. S. and DELOVITCH T. L. (1993): Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87-99.
45. RIDGWAY W. M., ITO H., FASSO M., YU C. and FATHMAN C. G. (1998): Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J. Exp. Med., 188, 2267-2275.
46. RISSOAN M. C., SOUMELIS V., KADOWAKI N., GROUARD G., BRIERE F., MALEFYT R. D. and LIU Y. L. (1999): Reciprocal control of T helper cell and dendritic cell differentiation. Science, 283, 1183-1186.
47. SARAVIA-FERNANDEZ F., DURANT S., EL HASNAOUI A., DARDENNE M. and HOMO-DELARCHE F. (1996): Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity, 24, 113-121.
48. SERREZE D. V., CHAPMAN H. D., VARNUM D. S., HANSON M. S., REIFSNYDER P. C., RICHARD S. D., FLEMING S. A., LEITER E. H. and SHULTZ L. D. (1996): B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new "speed congenic" stock of NOD. Ig mu(null) mice. J. Exp. Med., 184, 2049-2053.
49. SERREZE D. V., FLEMING S. A., CHAPMAN H. D., RICHARD S. D., LEITER E. H. and TISCH R. M. (1998): B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol., 161, 3912-3918.
50. SERREZE D. V., GAEDEKE J. W. and LEITER E. H. (1993): Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD Lt mice. Defective regulation of cytokine receptors and protein-kinase-C. Proc. Acad. Natl. Sci. USA, 90, 9625-9629.
51. SERREZE D. V., GASKINS H. R. and LEITER E. H. (1993): Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol., 150, 2534-2543.
52. SERREZE D. V. and LEITER E. H. (1994): Genetic and pathogenic pasis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol., 6, 900-906.
53. SINGH B., PRANGE S. and JEVNIKAR A. M. (1998): Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Semin. Immunol., 10, 79-86.
54. STEINMAN R. M. (1991): The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
55. TAKAHASHI K., HONEYMAN M. C. and HARRISON L. C. (1998): Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J. Immunol., 161, 2629-2635.
56. TODD J. A., BELL J. I. and MCDEVITT H. O. (1987): HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature, 329, 599-604.
57. TREMBLEAU S., PENNA G., GREGORI S., CHAPMAN H. D., SERREZE D. V., MAGRAM J. and ADORINI L. (1999): Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol., 163, 2960-2968.
58. VAN PARIJS L., PEREZ V. L. and ABBAS A. K. (1998): Mechanisms of peripheral T cell tolerance. Novartis Found. Symp., 215, 5-14.
59. WICKER L. S. (1997): Major histocompatibility complex-linked control of autoimmunity. J. Exp. Med., 186, 973-975.
60. WICKER L. S., MILLER B. J. and MULLEN Y. (1986): Tranfer of autoimmune diabetes-mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 35, 855-860.
61. WICKER L. S., TODD J. A. and PETERSON L. B. (1995): Genetic-control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol., 13, 179-200.
62. WINZLER C., ROVERE P., RESCIGNO M., GRANUCCI F., PENNA G., ADORINI L., ZIMMERMANN V. S., DAVOUST J. and RICCIAR-DI-CASTAGNOLI P. (1997): Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med., 185, 317-328.
63. YOUNG J. W. and STEINMAN R. M. (1996): The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation. Stem Cells, 14, 376-387.
64. ZIEGLER A. G., VARDI P., RICKER A. T., HATTORI M., SOELDNER J. S. and EISENBARTH G. S. (1989): Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes. Diabetes, 38, 358-363.